Fausto J Rodriguez
Overview
Explore the profile of Fausto J Rodriguez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
220
Citations
7786
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fernandez E, Mai W, Song K, Bayley N, Kim J, Zhu H, et al.
Nat Commun
. 2024 Nov;
15(1):10089.
PMID: 39572533
Genomic profiling often fails to predict therapeutic outcomes in cancer. This failure is, in part, due to a myriad of genetic alterations and the plasticity of cancer signaling networks. Functional...
2.
Lucas C, Gross A, Romo C, Dehner C, Lazar A, Miettinen M, et al.
Neuro Oncol
. 2024 Nov;
27(3):616-624.
PMID: 39500722
Consensus recommendations published in 2017 histologically defining atypical neurofibromatous neoplasm of uncertain biologic potential (ANNUBP) and malignant peripheral nerve sheath tumor (MPNST) were codified in the 2021 WHO Classification of...
3.
Chang M, Sherief M, Ioannou M, Chinnasamy V, Chen L, Frost M, et al.
Acta Neuropathol Commun
. 2024 Oct;
12(1):172.
PMID: 39472976
Background: NF1 inactivation is associated with sensitivity to MEK inhibitor targeted therapy in low-grade and some high-grade gliomas. NF1 loss may also be a harbinger of exploitable vulnerabilities in IDH-wildtype...
4.
Zhang L, Maalouf A, Makri S, Banerjee J, Suru A, Tam A, et al.
Clin Cancer Res
. 2024 Sep;
30(23):5459-5472.
PMID: 39321200
Purpose: Malignant peripheral nerve sheath tumors (MPNST) are aggressive soft-tissue sarcomas and the leading cause of mortality in individuals with neurofibromatosis type 1 (NF1). Despite many clinical trials, outcomes for...
5.
Furnari F, Anastasaki C, Bian S, Fine H, Koga T, Le L, et al.
Dis Model Mech
. 2024 Feb;
17(2).
PMID: 38353122
Nervous system tumors, particularly brain tumors, represent the most common tumors in children and one of the most lethal tumors in adults. Despite decades of research, there are few effective...
6.
Ioannou M, Zhang L, Schatz K, Rodriguez F, Ahlawat S, Gocke C, et al.
Neurooncol Adv
. 2023 Oct;
5(1):vdad125.
PMID: 37841697
No abstract available.
7.
Wali A, Yang R, Merbs S, Rodriguez F, Eberhart C, Lucas C
J Neuropathol Exp Neurol
. 2023 Oct;
82(11):963-965.
PMID: 37837311
No abstract available.
8.
Milde T, Fangusaro J, Fisher M, Hawkins C, Rodriguez F, Tabori U, et al.
Neuro Oncol
. 2023 Sep;
25(11):1920-1931.
PMID: 37738646
Pediatric low-grade gliomas (pLGGs) are the most common brain tumor in young children. While they are typically associated with good overall survival, children with these central nervous system tumors often...
9.
Zhou B, Milman T, Rodriguez F, Turbin R, Langer P
Ophthalmic Plast Reconstr Surg
. 2023 Aug;
40(1):e1-e4.
PMID: 37552498
A 52-year-old woman presented with a 6-month history of progressive right proptosis associated with intermittent right retrobulbar and facial pain. MRI revealed a heterogeneously enhancing, well-circumscribed, ovoid, soft tissue mass...
10.
Cohen K, Munjapara V, Aguilera D, Castellino R, Stapleton S, Landi D, et al.
Clin Cancer Res
. 2023 Jul;
29(24):5031-5037.
PMID: 37498309
Purpose: Treatment of wingless (WNT)-activated medulloblastoma (WNT+MB) with surgery, irradiation (XRT), and chemotherapy results in excellent outcomes. We studied the efficacy of therapy de-intensification by omitting XRT entirely in children...